EPCs exist in the bone marrow stem cell niche and are mobilised in response to chemokines and growth factors known to be upregulated in stroke including Stromal cell-derived factor 1 (SDF-1) and its cellular receptor C-X-C chemokine receptor type 4 (CXCR4) [42]. Here, CXCR4 is linked to stroke disorder.